Friday, 20 November 2026European Markets

HOFSETH BIOCARE Stock Rises 9% So Far On Friday, Outperforms Market

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

At 11:43 EST on Friday, shares of HOFSETH BIOCARE (HBC.OL) surged by 9.83% to close at kr3.24 at 11:43 EST - marking an upward movement from their last closing price at kr2.95. Although still 25.32% below their 52-week high of kr3.95, the increase suggests the stock is moving in an optimistic manner similar to Oslo Bors Benchmark Index_GI as a whole.

About Hofseth BioCare ASA

Hofseth BioCare ASA of Alesund, Norway serves as a provider of pet and consumer health ingredients both within Norway and internationally. Products offered include Brilliant and OmeGo salmon oils as well as ProGo Salmon Protein Powder.

Financial Health Concerns

However, despite HBC.OL's stock rally, its financial health remains cause for serious concern. Over the past year it reported negative earnings per share of kr-0.37 and its return on equity is also disconcertingly negative at 126.49% indicating significant shareholder equity losses.

Stock Stability

On a positive note, however, the value of HOFSETH BIOCARE's shares remains well above its 50-day moving average of kr2.87 and slightly above its 200-day moving average of kr2.96, suggesting relative mid- to long-term stability.

Revenue Growth and Profitability

As well, the company has witnessed impressive revenue growth; its year-on-year quarterly revenue growth increased by 45.4% year over year to reach 134.43 million during its twelve trailing months period. Unfortunately, however, EBITDA stands at a negative number at -39.65; thus raising concerns over its profitability.

Conclusion

Overall, HOFSETH BIOCARE's stock performance indicates an upward trajectory with promising revenue growth and worrying profitability metrics that call attention to the need for strategic decision-making in order to enhance shareholder returns and bolster overall financial status.

More news about HOFSETH BIOCARE (HBC.OL).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.

  1. Published before we listed source documents with each article.
  2. Published 4 Aug 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›